Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$530M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$448M |
| 3 |
CERN
Cerner Corp
CERN
|
+$285M |
| 4 |
Exxon Mobil
XOM
|
+$252M |
| 5 |
Norfolk Southern
NSC
|
+$246M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.37B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1B |
| 4 |
NVIDIA
NVDA
|
+$836M |
| 5 |
Tesla
TSLA
|
+$595M |
Sector Composition
| 1 | Technology | 16.62% |
| 2 | Financials | 15.26% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 9.83% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CEMIG Preferred Shares
CIG
$5.95B
| $6.39M | ﹤0.01% |
3,355,509
-10,226,029
| -75% | -$19.5M |
|
2002
Viatris
VTRS
$11.2B
| $6.38M | ﹤0.01% |
586,677
-1,290,358
| -69% | -$14M |
|
2003
Builders FirstSource
BLDR
$15.5B
| $6.38M | ﹤0.01% |
98,886
-405,189
| -80% | -$26.2M |
|
|
AMK
2004
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $6.37M | ﹤0.01% |
286,363
+88,322
| +45% | +$1.97M |
|
|
NGM
2005
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $6.37M | ﹤0.01% |
417,416
-116,933
| -22% | -$1.78M |
|
|
OSH
2006
DELISTED
Oak Street Health, Inc.
OSH
| $6.37M | ﹤0.01% |
236,816
+78,397
| +49% | +$2.11M |
|
|
ELIQ
2007
DELISTED
Electriq Power Holdings, Inc.
ELIQ
| $6.36M | ﹤0.01% |
650,057
-546,897
| -46% | -$5.35M |
|
|
OHPA
2008
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
| $6.36M | ﹤0.01% |
650,501
-18,097
| -3% | -$177K |
|
2009
Vaxcyte
PCVX
$4.02B
| $6.35M | ﹤0.01% |
262,720
-23,603
| -8% | -$570K |
|
2010
Reinsurance Group of America
RGA
$12.5B
| $6.33M | ﹤0.01% |
57,851
-152,824
| -73% | -$16.7M |
|
2011
Dine Brands
DIN
$379M
| $6.33M | ﹤0.01% |
81,158
+68,660
| +549% | +$5.35M |
|
2012
Hancock Whitney
HWC
$5.35B
| $6.31M | ﹤0.01% |
121,012
-312,462
| -72% | -$16.3M |
|
2013
Vanguard High Dividend Yield ETF
VYM
$64.9B
| $6.31M | ﹤0.01% |
56,210
+6,943
| +14% | +$779K |
|
2014
iShares MSCI United Kingdom ETF
EWU
$2.94B
| $6.31M | ﹤0.01% |
+187,509
| New | +$6.31M |
|
|
WW
2015
DELISTED
WW International
WW
| $6.3M | ﹤0.01% |
616,080
+3,123
| +0.5% | +$31.9K |
|
2016
Moelis & Co
MC
$5.52B
| $6.3M | ﹤0.01% |
134,103
-355,944
| -73% | -$16.7M |
|
2017
Mercury Insurance
MCY
$4.35B
| $6.29M | ﹤0.01% |
+114,332
| New | +$6.29M |
|
|
LMACA
2018
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
| $6.27M | ﹤0.01% |
632,486
+5,665
| +0.9% | +$56.1K |
|
2019
QuantumScape
QS
$5.86B
| $6.25M | ﹤0.01% |
312,609
-289,630
| -48% | -$5.79M |
|
2020
Kennametal
KMT
$1.59B
| $6.25M | ﹤0.01% |
218,326
-118,209
| -35% | -$3.38M |
|
|
LOKM
2021
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
| $6.24M | ﹤0.01% |
636,432
+156,822
| +33% | +$1.54M |
|
|
SPCMU
2022
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
| $6.24M | ﹤0.01% |
+620,000
| New | +$6.24M |
|
|
ARGO
2023
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $6.23M | ﹤0.01% |
150,982
+59,014
| +64% | +$2.44M |
|
2024
Amphastar Pharmaceuticals
AMPH
$1.27B
| $6.22M | ﹤0.01% |
173,321
+100,140
| +137% | +$3.59M |
|
|
CAN
2025
Canaan Creative
CAN
$384M
| $6.22M | ﹤0.01% |
1,145,075
+333,201
| +41% | +$1.81M |
|